Legal & General Group’s Edgewise Therapeutics EWTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $686K | Buy |
|
|||||
|
2025
Q1 | $1.11M | Buy |
|
|||||
|
2024
Q4 | $1.34M | Buy |
|
|||||
|
2024
Q3 | $1.17M | Buy |
|
|||||
|
2024
Q2 | $707K | Buy |
|
|||||
|
2024
Q1 | $520K | Buy |
|
|||||
|
2023
Q4 | $182K | Buy |
|
|||||
|
2023
Q3 | $20.2K | Sell |
|
|||||
|
2023
Q2 | $31.5K | Buy |
|
|||||
|
2023
Q1 | $24.2K | Hold |
|
|||||
|
2022
Q4 | $32.5K | Buy |
|
|||||
|
2022
Q3 | $25K | Buy |
|
|||||
|
2022
Q2 | $20K | Sell |
|
|||||
|
2022
Q1 | $44K | Sell |
|
|||||
|
2021
Q4 | $71K | Buy |
|
|||||
|
2021
Q3 | $31K | Hold |
|
|||||
|
2021
Q2 | $40K | Buy |
|